Khiron Life Sciences Corp. announced that following the previously announced resignation of Sidney Himmel from Khiron's Board of Directors and as Chair of the Audit Committee effective November 29, 2019, Deborah Rosati was appointed as a director of the Company and as Chair of the Audit Committee. Alvaro Torres, Khiron's CEO, was appointed as Interim Chair of the Board until Mr. Himmel's successor was appointed. The Company's search for a new independent director and member of the audit committee has been delayed due to COVID-19. Mr. Torres was appointed to fill the vacancy on the Audit Committee effective April 22, 2020.